Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
I have appreciated the support from my manager, leadership and team. The environment at KPTI is fast paced with opportunity to innovate and try new things - with a priority and focus on people and patients first.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
Teamwork and support from my KPTI colleagues
Was macht Sie bei der Arbeit am glücklichsten?
Being a resource and cross functional partner to my KPTI colleagues and leadership.
Was sind einige der besten Dinge an Ihrem Team?
We are one team. Everyone supports each other regardless of their role or function. This allows us to achieve our goals and objectives.
Other Employee Reviews for Karyopharm Therapeutics
×